BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 14642940)

  • 1. [Pap test: liquid-based--thin-layer. A new method: results].
    Hammou JC; Bertino B; Blancheri A; Kon Man P; Patoz L
    Gynecol Obstet Fertil; 2003 Oct; 31(10):833-40. PubMed ID: 14642940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear.
    Wang N; Emancipator SN; Rose P; Rodriguez M; Abdul-Karim FW
    Acta Cytol; 2002; 46(3):453-7. PubMed ID: 12040636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer.
    Weintraub J; Morabia A
    Diagn Cytopathol; 2000 Jan; 22(1):52-9. PubMed ID: 10613975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin-layer technology: tempered enthusiasm.
    Kurtycz DF; Hoerl HD
    Diagn Cytopathol; 2000 Jul; 23(1):1-5. PubMed ID: 10907923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Thin Prep Pap Test in clinical practice.
    Guidos BJ; Selvaggi SM
    Diagn Cytopathol; 1999 Feb; 20(2):70-3. PubMed ID: 9951600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
    Bai H; Sung CJ; Steinhoff MM
    Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection.
    Ronnett BM; Manos MM; Ransley JE; Fetterman BJ; Kinney WK; Hurley LB; Ngai JS; Kurman RJ; Sherman ME
    Hum Pathol; 1999 Jul; 30(7):816-25. PubMed ID: 10414501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
    Park J; Jung EH; Kim C; Choi YH
    Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
    Sass MA
    Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology.
    Wang TY; Chen HS; Yang YC; Tsou MC
    J Formos Med Assoc; 1999 Jul; 98(7):500-5. PubMed ID: 10463000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
    Monsonego J; Autillo-Touati A; Bergeron C; Dachez R; Liaras J; Saurel J; Zerat L; Chatelain P; Mottot C
    Br J Cancer; 2001 Feb; 84(3):360-6. PubMed ID: 11161401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital.
    Carpenter AB; Davey DD
    Cancer; 1999 Jun; 87(3):105-12. PubMed ID: 10385440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
    Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
    Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.